Yeongsin Kim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Yeongsin Kim has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Chang-Hyeon Choi
Department of Veterinary Internal Medicine College of Veterinary Medicine Chonnam Nation University Gwangju South Korea
1 shared publication - Chang-Min Lee
Department of Veterinary Internal Medicine, College of Veterinary Medicine and BK21 FOUR program, Chonnam National University
1 shared publication - Dong-Il Kim
Department of Veterinary Physiology, College of Veterinary Medicine, Chonnam National University, Gwangju, Korea
1 shared publication - Edzel Evallo
Department of Veterinary Physiology, College of Veterinary Medicine, Chonnam National University, Gwangju, Korea
1 shared publication - Jun Wu
Life Sciences Institute, University of Michigan, Ann Arbor, MI
1 shared publication - Junhyeong Lee
Department of Veterinary Physiology, College of Veterinary Medicine
1 shared publication
Latest Publications
- Open Access
- 17 February 2026
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 136 (8)
Distinct HIF1α and HIF2α functions control skeletal muscle metabolism and erythropoiesis
Skeletal muscle frequently encounters hypoxic stress, particularly during exercise, but the specific functions of the hypoxia-inducible factors HIF1α and HIF2α within myofibers remain unclear due to the lack of appropriate in vivo models. Here, we generated 3 complementary mouse models, myofiber-specific triple-PHD knockout (PHD mTKO) and inducible myofiber-specific overexpression of stabilized HIF1α or HIF2α, to delineate isoform-specific roles of HIFα signaling in skeletal muscle. HIF1α stabilization increased the proportion of oxidative fibers yet paradoxically impaired exercise capacity and mitochondrial function. In contrast, HIF2α activation protected against diet-induced obesity, improved glucose tolerance, and maintained mitochondrial function without altering fiber-type composition. Notably, HIF2α stabilization markedly elevated erythropoietin (EPO) expression in skeletal muscle and serum. Myofiber-specific deletion of EPO in the PHD mTKO background abolished polycythemia, demonstrating that this phenotype is driven specifically by muscle-derived EPO. Together, these findings uncover distinct roles of HIF1α and HIF2α in regulating muscle metabolism and mitochondrial function and establish the PHD–HIF2α axis as a myofiber-derived driver of systemic EPO production.
- 17 February 2026
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 136 (8)
Open AccessDistinct HIF1α and HIF2α functions control skeletal muscle metabolism and erythropoiesis
Skeletal muscle frequently encounters hypoxic stress, particularly during exercise, but the specific functions of the hypoxia-inducible factors HIF1α and HIF2α within myofibers remain unclear due to the lack of appropriate in vivo models. Here, we generated 3 complementary mouse models, myofiber-specific triple-PHD knockout (PHD mTKO) and inducible myofiber-specific overexpression of stabilized HIF1α or HIF2α, to delineate isoform-specific roles of HIFα signaling in skeletal muscle. HIF1α stabilization increased the proportion of oxidative fibers yet paradoxically impaired exercise capacity and mitochondrial function. In contrast, HIF2α activation protected against diet-induced obesity, improved glucose tolerance, and maintained mitochondrial function without altering fiber-type composition. Notably, HIF2α stabilization markedly elevated erythropoietin (EPO) expression in skeletal muscle and serum. Myofiber-specific deletion of EPO in the PHD mTKO background abolished polycythemia, demonstrating that this phenotype is driven specifically by muscle-derived EPO. Together, these findings uncover distinct roles of HIF1α and HIF2α in regulating muscle metabolism and mitochondrial function and establish the PHD–HIF2α axis as a myofiber-derived driver of systemic EPO production.